479 filings
Page 15 of 24
4
Mehrdad Mobasher
30 Jan 19
Corvus Pharmaceuticals / Mehrdad Mobasher ownership change
4:07pm
3
Mehrdad Mobasher
30 Jan 19
Corvus Pharmaceuticals / Mehrdad Mobasher ownership change
4:05pm
3
CRVS
Corvus Pharmaceuticals Inc
30 Jan 19
Corvus Pharmaceuticals / Linda S Grais ownership change
4:05pm
8-K
CRVS
Corvus Pharmaceuticals Inc
28 Jan 19
Corvus Pharmaceuticals Announces Appointment of New Member of Board of Directors and Hiring of Chief Medical Officer
4:10pm
8-K
CRVS
Corvus Pharmaceuticals Inc
10 Jan 19
Corvus Announces Presentation of Preclinical Data on CPI-818, a First-in-class Covalent Inhibitor of ITK Targeting T-Cell Lymphomas
8:35am
8-K
CRVS
Corvus Pharmaceuticals Inc
8 Jan 19
Regulation FD Disclosure
8:30am
4
Richard A Miller MD
31 Dec 18
Corvus Pharmaceuticals / RICHARD A MD MILLER ownership change
4:16pm
4
CRVS
Corvus Pharmaceuticals Inc
27 Dec 18
Corvus Pharmaceuticals / LEIV LEA ownership change
4:08pm
4
CRVS
Corvus Pharmaceuticals Inc
26 Dec 18
Corvus Pharmaceuticals / RICHARD A MD MILLER ownership change
4:05pm
8-K
CRVS
Corvus Pharmaceuticals Inc
14 Dec 18
Departure of Directors or Certain Officers
4:15pm
4
William Benton Jones
14 Dec 18
Corvus Pharmaceuticals / William Benton Jones ownership change
4:09pm
4
Richard A Miller MD
14 Dec 18
Corvus Pharmaceuticals / RICHARD A MD MILLER ownership change
4:07pm
4
Joseph J Buggy
14 Dec 18
Corvus Pharmaceuticals / Joseph J Buggy ownership change
4:06pm
4
Leiv Lea
14 Dec 18
Corvus Pharmaceuticals / LEIV LEA ownership change
4:06pm
4
Daniel W. Hunt
14 Dec 18
Corvus Pharmaceuticals / Daniel W. Hunt ownership change
4:05pm
4
Erik J. Verner
14 Dec 18
Corvus Pharmaceuticals / Erik J. Verner ownership change
4:05pm
4
Richard A Miller MD
10 Dec 18
Corvus Pharmaceuticals / RICHARD A MD MILLER ownership change
4:05pm
4
CRVS
Corvus Pharmaceuticals Inc
6 Dec 18
Corvus Pharmaceuticals / RICHARD A MD MILLER ownership change
4:06pm
8-K
CRVS
Corvus Pharmaceuticals Inc
13 Nov 18
Corvus Pharmaceuticals Announces Updated Results from Ongoing Clinical Studies of Lead Programs, CPI-444 and CPI-006, at SITC 33rd Annual Meeting
8:30am
10-Q
2018 Q3
CRVS
Corvus Pharmaceuticals Inc
Quarterly report
1 Nov 18
4:41pm